After a long and arduous battle, politician Piotr Krzysztof Liroy-Marzec passed a new legislation that allows Polish pharmacies to make cannabis-based medicine using imported ingredients.

Starting Nov. 1, pharmacies in Poland will be able to treat people with cannabis for medical reasons, as long as it has been registered with the country’s Office for Registration of Medical Products.

The new laws will allow cannabis to be used to treat a wide range of ailments, including epilepsy, nausea caused by chemotherapy, chronic pain and symptoms of multiple sclerosis.

According to the Polish Pharmaceutical Chamber, Polish pharmacies are already prepared to make the products and they would be able to go through special training if necessary.

“Given the fact that there are nearly 15,000 pharmacies in Poland, an overwhelming majority is authorized to make prescription drugs – that’s around 90 percent,” a spokesman said. “It is estimated that up to 300,000 patients could qualify for medical marijuana treatment.”

Liroy had introduced a legislative measure for the legalization medical cannabis early in 2016, but was forced to postpone the bill in February. After several revisions, 440 lawmakers voted in favor and just two voted against the bill. The law excludes the social use of cannabis.

“People are dying every day because of the current laws. I am attending their funerals and you should start attending them too, talk to their families and tell them face to face what you keep saying to media,” Liroy said.

However, the new legislation does not allow for a system to cultivate cannabis, and cannabis products will have to be imported from other countries in the European Union.

Cannabis will only be available through registered pharmacies, and patients must receive permission to use medical cannabis from a regional pharmaceutical inspector along with a medical authorization from a physician.